Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity

Principles of Drug Metabolism

Testa, B. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc033.pub2 · Cited by 14

Urinary Biomarkers of Trimethoprim Bioactivation in Vivo Following Therapeutic Dosing in Children

van Haandel, L., Goldman, J. L., Pearce, R. E., & Leeder, J. S. (2013) · Chemical Research in Toxicology · doi:10.1021/tx4003325 · Cited by 13

Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study

Lavergne, S. N., Volkman, E. M., Maki, J. E., Yoder, A. R., & Trepanier, L. A. (2004) · Toxicology · doi:10.1016/j.tox.2004.11.009 · Cited by 12

Mechanistic Study on Aniline-Induced Erythrocyte Toxicity

Singh, H. S., Purnell, E. T., & Smith, C. (2007) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/v10004-007-0018-2 · Cited by 12

Evaluation of Polymorphisms in the Sulfonamide Detoxification Genes CYB5A and CYB5R3 in Dogs with Sulfonamide Hypersensitivity

Funk‐Keenan, J., Sacco, J., Wong, Y. Y., Rasmussen, S., Motsinger‐Reif, A. A., & Trepanier, L. A. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2012.00965.x · Cited by 12

Reactions of Nitrosoarenes with SH Groups

Eyer, P., & Gallemann, D. (2009) · Patai's chemistry of functional groups · doi:10.1002/9780470682531.pat0093 · Cited by 12

Antibiotic prophylaxis in immunosuppressed patients – Missed opportunities from trimethoprim-sulfamethoxazole allergy label

Lee, W., Lam, L., Bacchi, S., Jiang, M., Inglis, J. M., Smith, W., & Hissaria, P. (2024) · World Allergy Organization Journal · doi:10.1016/j.waojou.2023.100856 · Cited by 12

The discovery of a potent Na v 1.3 inhibitor with good oral pharmacokinetics

Pryde, D. C., Swain, N. A., Stupple, P. A., West, C. W., Marron, B. E., Markworth, C. J., Printzenhoff, D., Lin, Z., Cox, P. J., Suzuki, R., et al. (2017) · MedChemComm · doi:10.1039/c7md00131b · Cited by 11

CYP1A1, GCLC, AGT, AGTR1 gene–gene interactions in community-acquired pneumonia pulmonary complications

Salnikova, L. E., Валерьевна, С. Т., Golubev, A. M., Rubanovich, A. V., & Moroz, V. V. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2727-8 · Cited by 11

RNA expression profiling in sulfamethoxazole‐treated patients with a range of in vitro lymphocyte cytotoxicity phenotypes

Reinhart, J. M., Rose, W. E., Panyard, D. J., Newton, M. A., Liebenstein, T., Yee, J. S., & Trepanier, L. A. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.388 · Cited by 11

Dapsone impairs the bile salt-independent fraction of bile flow in rats: Possible involvement of its N-hydroxylated metabolite

Veggi, L. M., Crocenzi, F. A., Roma, M. G., & Mottino, A. D. (2005) · Toxicology · doi:10.1016/j.tox.2005.03.002 · Cited by 11

Pharmacogenetics and blood dyscrasias

Spielberg, S. P. (1996) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1996.tb01653.x · Cited by 11

Adverse Drug Effect—Reactive Metabolites and Idiosyncratic Drug Reactions: Part I

Gibaldi, M., & Gibaldi, M. (1992) · Annals of Pharmacotherapy · doi:10.1177/106002809202600317 · Cited by 11

HIV-1 tat expression and sulphamethoxazole hydroxylamine mediated oxidative stress alter the disulfide proteome in Jurkat T cells

Adeyanju, K., Bend, J. R., Rieder, M. J., & Dekaban, G. A. (2018) · Virology Journal · doi:10.1186/s12985-018-0991-x · Cited by 10

Dapsone‐Associated Methemoglobinemia in a Patient With SlowNAT2*5B Haplotype and Impaired Cytochromeb5Reductase Activity

Abouraya, M., Sacco, J., Hayes, K., Thomas, S. S., Kitchens, C. S., & Trepanier, L. A. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010393343 · Cited by 9

Extrahepatic Targets and Cellular Reactivity of Drug Metabolites

Orhan, H. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140826113716 · Cited by 10

Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites

Sanderson, J. P., Hollis, F. J., Maggs, J. L., Clarke, S. E., Naisbitt, D. J., & Park, B. K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021246 · Cited by 8

Oral bioavailability of sulphonamides in ruminants: A comparison between sulphamethoxazole, sulphatroxazole, and sulphamerazine, using the dwarf goat as animal model

RÁTZ, V., Maas-Bakker, R. F., Semjén, G., van Miert, A. S. J. P. A. M., & Witkamp, R. F. (1995) · Veterinary Quarterly · doi:10.1080/01652176.1995.9694538 · Cited by 8

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b 5 expression and impaired reduction of sulfamethoxazole hydroxylamine

Bhusari, S. S., Abouraya, M., Padilla, M. L., Pinkerton, M. E., Drescher, N. J., Sacco, J., & Trepanier, L. A. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0530-z · Cited by 7

The Effect of Cimetidine on the Formation of Sulfamethoxazole Hydroxylamine in Patients with Human Immunodeficiency Virus

Lehmann, D. F., Newman, N. B., & Morse, P. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04454.x · Cited by 7

Adverse reactions to trimethoprim-sulfamethoxazole

Lee, B. L. (1996) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02771757 · Cited by 6

T Cell Responses to Drugs and Drug Metabolites

Earnshaw, C. J., Pecaric-Petkovic, T., Park, B. K., & Naisbitt, D. J. (2013) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-0726-5_10 · Cited by 6

Comparisons of Oxidative Metabolism and Reductive Capacity in Sulfonamide‐Tolerant and ‐Intolerant Patients with Human Immunodeficiency Virus

Lehmann, D. F., Holohan, P. D., & Blair, D. C. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04169.x · Cited by 5

Antigenicity of sulfanilamide and its metabolites using fluorescent-labelled compounds

Eyanagi, R., Toda, A., Ishii, Y., Saitō, H., Soeda, S., Shimeno, H., & Shigematsu, H. (2005) · Xenobiotica · doi:10.1080/00498250500251533 · Cited by 6

Combination Exposure to Zidovudine plus Sulfamethoxazole-Trimethoprim Diminishes B-Lymphocyte Immune Responses toPneumocystis murinaInfection in Healthy Mice

Feola, D. J., & Garvy, B. A. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.13.2.193-201.2006 · Cited by 5

Zidovudine plus sulfamethoxazole–trimethoprim adversely affects B lymphocyte maturation in bone marrow of normal mice

Feola, D. J., & Garvy, B. A. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.06.011 · Cited by 5

Effect of lipopolysaccharide (LPS)-evoked host defense activation on hepatic microsomal formation and reduction of sulfamethoxazole hydroxylamine in the rat12Abbreviations: ADR, adverse drug reaction; CYP, cytochrome P450; LPS, lipopolysaccharide; NMHR, NADH-dependent microsomal hydroxylamine reductase; SMX, sulfamethoxazole; SMX-HA, sulfamethoxazole hydroxylamine; and SMX-TMP, sulfamethoxazole-trimethoprim.

Cribb, A. E., McQuaid, T., & Renton, K. W. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00691-8 · Cited by 5

Evaluation of Strategies for the Assessment of Drug–Drug Interactions Involving Cytochrome P450 Enzymes

Reinen, J., Smit, M., & Wenker, M. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0485-7 · Cited by 4

Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection

Wong, Y. Y., Rakasz, E. G., Gasper, D. J., Friedrich, T. C., & Trepanier, L. A. (2016) · Toxicology · doi:10.1016/j.tox.2016.08.010 · Cited by 4

Biomimetic trapping cocktail to screen reactive metabolites: use of an amino acid and DNA motif mixture as light/heavy isotope pairs differing in mass shift

Hosaka, S., Honda, T., Lee, S. H., & Oe, T. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1057-z · Cited by 4

Alpha-hydroxybutyrate dehydrogenase and the diagnosis of painful crisis in sickle cell anaemia.

Akenzua, G. I., Ihongbe, J. C., & Asemota, H. N. (1992) · PubMed · Cited by 3

Predicting Drug‐Induced Hepatotoxicity:In Vitro,In SilicoandIn VivoApproaches

Xu, J. J., Kalgutkar, A. S. S., Will, Y., Dykens, J. A., Tengstrand, E., & Hsieh, F. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627448.ch15 · Cited by 3

Populations at risk: Predicting and preventing drug-induced disease

Spielberg, S. P. (1993) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630020707 · Cited by 2

Pathophysiologic Mechanisms of Immune-mediated Drug Hypersensitivity Reactions to Sulfonamides

Sultan, E. A. (2015) · Scholarship@Western (Western University) · Cited by 2

Pharmacogenetics of Adverse Drug Reactions

Alfirevic, A., & Park, B. (2006) · CRC Press eBooks · doi:10.3109/9781420016697-6 · Cited by 2

Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk

Wong, Y. Y., Johnson, B. P., Friedrich, T. C., & Trepanier, L. A. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.312 · Cited by 2

Bioactivation I: Bioactivation by Cytochrome P450s

Dalvie, D. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm072 · Cited by 1

Sulfonamide-induced cutaneous drug reactions

Vyas, P. M. (2006) · doi:10.17077/etd.rttumisz · Cited by 2

N-Acetyltransferase (NAT) 1 and NAT2 Enzyme Activities Drive Interindividual Variability in Sulfamethoxazole N-Acetylation

Lanphier, R. M., Latham, B. D., Gerringer, A. J., Interrante, T., Jones, C. D., De Buysscher, T., Fallon, J. K., & Jackson, K. D. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100195 · Cited by 1

Phase II metabolic transformations

Ashton, M., Groundwater, P. W., Stocker, S., & Todd, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99133-9.00002-4 · Cited by 1

The Role of In Vivo, In Vitro and Pharmacogenomic Diagnostic Approaches to Sulfonamide Allergy

Waldron, J. L., Krantz, M. S., Sukasem, C., & Norton, A. E. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2026.02.029 · Cited by 1

Canadian Content in the Pages of Drug Metabolism and Disposition: A Comprehensive Historical Analysis

Riddick, D. S. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001517 · Cited by 1

The role of potential antioxidant in medicinal drug-induced oxidative stress

Fan, W. (2014) · Cited by 1

Sulfonamide Drug Allergy

Dorn, J. M., & Volcheck, G. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48551-7.00014-6 · Cited by 4

Role of Metabolism in Toxicity of Drugs in Humans

Kalgutkar, A. S. S., & Bauman, J. N. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm127

Structural Alert and Reactive Metabolite Analysis for the Top 200 Drugs in the US Market by Prescription

Kalgutkar, A. S. S., Dalvie, D., Obach, R. S., & Smith, D. A. (2012) · Methods and principles in medicinal chemistry · doi:10.1002/9783527655748.ch12

EFFECT OF COMBINATION EXPOSURE TO ZIDOVUDINE AND SULFAMETHOXAZOLE-TRIMETHOPRIM ON IMMUNE RESPONSE IN MICE AND HUMANS

Feola, D. J. (2005) · UKnowledge (University of Kentucky)

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b 5 expression and impaired reduction of sulfamethoxazole hydroxylamine Sachin BhusariMahmoud AbourayaMarcia L. PadillaMarie E. Pinkerton • Nicholas J. DrescherJames C. SaccoLauren A. Trepanier

Pinkerton, M. E. (2010)

Mechanisms of NSAID-Induced Hepatotoxicityon Nimesulide

Boelsterli, U. A. (2002)

Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis

Dijkstra, J. A. (2017) · University of Groningen research database (University of Groningen / Centre for Information Technology)

Characterizing T Cell Phenotype In Patients With Hypersensitivity Reactions To Sulfamethoxazole And Beta-Lactam Antibiotics

Caron, C. (2020) · Scholarship@Western (Western University)

Principles of Drug Metabolism

Dalvie, D., & Testa, B. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc033.pub3

Adverse Reactions to Trimethoprim-Sulfamethoxazole

Lee, B. L. (1997) · Humana Press eBooks · doi:10.1007/978-1-4612-3966-6_7

Population pharmacokinetic modeling and Monte Carlo simulation–based dosing optimization of trimethoprim–sulfamethoxazole in critically ill patients

Wang, M., Li, C., Fu, X., Wang, F., Zhou, X., Zhang, B., Xu, W., Liang, L., Lei, Z., Qu, H., et al. (2026) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-026-04019-5

Other Antimicrobial Drugs

Baldo, B. A., & Pham, N. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7261-2_6

Time-course of toxicity of reactive sulfonamide metabolites

Rieder, M. J., Krause, R. S., & Bird, I. A. (1995) · Toxicology · doi:10.1016/0300-483x(94)02900-f · Cited by 42

Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.

Rieder, M. J., Uetrecht, J., Shear, N. H., & Spielberg, S. P. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24502-5 · Cited by 148

Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine

Cribb, A. E., & Spielberg, S. P. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08652-0 · Cited by 65

Influence of reduced glutathione on the proliferative response of sulfamethoxazole‐specific and sulfamethoxazole‐metabolite‐specific human CD4+ T‐cells

Burkhart, C., von Greyerz, S., Depta, J. P. H., Naisbitt, D. J., Britschgi, M., Park, K. B., & Pichler, W. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703845 · Cited by 95

SULFAMETHOXAZOLE HYPERSENSITIVITY REACTIONS ARE MEDIATED BY A HYDROXYLAMINE METABOLITE

Rieder, M. J., Cannon, M., Uetrecht, J., & Soielbera, S. P. (1987) · Pediatric Research · doi:10.1203/00006450-198704010-00442